"Hearst Magazines and Yahoo may earn commission or revenue on some items through the links below." “My platelets are too low for an epidural,” she shared. “It was awful [before]. But I can do it one ...

Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to help address the underlying causes of ...

This might sound surprising, but getting diagnosed with immune thrombocytopenia (also known as idiopathic thrombocytopenic purpura, or ITP) can come as a relief. You can figure out ITP treatment, of ...

Sanofi ($SNYNF) announced an update on their ongoing clinical study. Study Overview Sanofi has completed an observational study titled “Cognitive ...

Recommendation based on LUNA 3 phase 3 study demonstrating rapid and durable platelet response and significant improvements in bleeding, quality of life measures, and other ITP symptoms If approved, ...

Sanofi’s Wayrilz, the first BTK inhibitor to treat immune thrombocytopenia gets European approval: Paris Saturday, December 27, 2025, 12:00 Hrs [IST] Sanofi, an R&D driven, AI-p ...

The European Commission has approved Wayrilz, a novel, oral, reversible, Bruton’s tyrosine kinase inhibitor, as a new treatment for immune ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through the links below." Mandy Moore revealed she has a rare blood disorder, immune thrombocytopenic purpura (ITP). The This ...

Novel treatment targets BTK through multi-immune modulation to help address root causes of ITP Approval based on LUNA 3 phase 3 study that demonstrated rapid and durable platelet response and ...